What is your perspective on the Indian health services market vis-a-vis the global market?
In the US, about 20 years back, there were at least 30 thousands laboratories but today there are top 4-5 major chains of organised laboratories, which constitute around 30% of the total market of pathological testing. Now the Indian market dynamics is also changing drastically the way US did. With more than 3000 labs and 90% of the total market share currently, the unorganised laboratories are growing at the rate of 10 15 %, while the organised corporate chains having less than 10% share of the total market are growing in a much faster rate at 25 30%, annually. In the scenario, Metropolis is also growing at a rate of 35 40% currently. Besides, in our country there is no regulation by the government to ensure the quality and authenticity of the pathological labs. Therefore, there is high risk of improper diagnosis by the doctors who bank upon the pathological tests’ results. In US there is CAP (College of American Pathologies), which is one of the expensive accreditations in the world
